A ‘perfect storm’ of spiralling haematology drug costs will require pragmatic and perhaps radical changes to pharmaceutical reimbursement systems such as the PBS, an Australian forum has been told. Experts have warned that haematologists may be unable to access the many high cost treatments coming out of drug company pipelines unless there are changes to ...
Can haematology weather the ‘perfect storm’ of high cost drugs?
By Michael Woodhead
21 Nov 2019